Overall, available data of aberrant NF-kB signaling in different canine cancers, and on the potential to inhibit NF-kB activity by using antineoplastic compounds, suggest that dog models may be a suitable model for comparative cancer biology studies on the regulatory mechanisms of NF-kB leading to DR in human cancers [54]. This evidence concerns the gene NFKB1 and cancer.